CN1698669A - Banxia Xiexin Decoction preparation and its preparation method and application - Google Patents
Banxia Xiexin Decoction preparation and its preparation method and application Download PDFInfo
- Publication number
- CN1698669A CN1698669A CN 200410018432 CN200410018432A CN1698669A CN 1698669 A CN1698669 A CN 1698669A CN 200410018432 CN200410018432 CN 200410018432 CN 200410018432 A CN200410018432 A CN 200410018432A CN 1698669 A CN1698669 A CN 1698669A
- Authority
- CN
- China
- Prior art keywords
- preparation
- banxia xiexin
- xiexin decoction
- banxia
- decoction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
技术领域technical field
本发明涉及中药复方半夏泻心汤制剂及其制备方法,尤其涉及以中药复方半夏泻心汤为活性成分的胶囊剂和片剂。The invention relates to a Chinese medicine compound Banxia Xiexin Decoction preparation and a preparation method thereof, in particular to capsules and tablets which take the Chinese medicine compound Banxia Xiexin Decoction as an active ingredient.
背景技术Background technique
浅表性胃炎是一种常见病、多发病,且病程长、易复发,西药治疗普遍采用三联或四联疗法,治疗费用高、副作用大。半夏泻心汤是张仲景所著《伤寒论》中的经典名方,为现代中药临床治疗慢性胃炎、胃溃疡的常用方,治疗效果好、复发率低且副作用小,但目前尚无该方制剂上市,临床应用以汤剂服用,服用量大,药物受胃排空影响也较大,给患者的治疗使用带来了不便。Superficial gastritis is a common and frequently-occurring disease with a long course and easy recurrence. Western medicine generally adopts triple or quadruple therapy, which has high treatment costs and large side effects. Banxia Xiexin Decoction is a classic prescription in "Treatise on Febrile Diseases" written by Zhang Zhongjing. It is a common prescription for modern Chinese medicine clinical treatment of chronic gastritis and gastric ulcer. It has good curative effect, low recurrence rate and few side effects, but there is no such prescription The preparation is on the market, and it is taken in decoction in clinical application. The dosage is large, and the medicine is also greatly affected by gastric emptying, which brings inconvenience to the treatment and use of patients.
发明内容Contents of the invention
本发明需要解决的技术问题是公开一种半夏泻心汤制剂及其制备方法和应用,以克服现有技术存在的服用量大,药物受胃排空影响也较大,给患者的治疗使用带来不便的缺陷。The technical problem to be solved in the present invention is to disclose a preparation of Banxia Xiexin Decoction and its preparation method and application, so as to overcome the problems in the prior art that the dosage is large, the medicine is also greatly affected by gastric emptying, and it is used for the treatment of patients. Inconvenient defect.
本发明的半夏泻心汤制剂包括治疗有效量的半夏泻心汤提取物和医药学上可接受的载体;The Banxia Xiexin Decoction preparation of the present invention comprises a therapeutically effective dose of Banxia Xiexin Decoction extract and a pharmaceutically acceptable carrier;
所说的半夏泻心汤提取物是采用如下重量份数配比的原料药提取的:Said Banxia Xiexin Decoction extract is extracted by adopting the raw material medicine of the following proportioning by weight:
药材半夏 18-24,黄芩 13-19,党参或人参 13-19,干姜 13-19,Medicinal Pinellia 18-24, Scutellaria baicalensis 13-19, Codonopsis or Ginseng 13-19, Dried Ginger 13-19,
大枣 13-19,炙甘草 7-13, 黄连 2-8。Jujube 13-19, Zhi Licorice 7-13, Coptidis 2-8.
所说的载体的加入量为半夏泻心汤提取物制剂重量的30%~80%;The added amount of said carrier is 30%-80% of the weight of the extract preparation of Banxia Xiexin Decoction;
所说的载体包括填充剂、崩解剂、润滑剂或湿润剂中的一种或一种以上;The carrier includes one or more of fillers, disintegrants, lubricants or wetting agents;
填充剂选自淀粉、预胶化淀粉、微晶纤维素、羧甲基纤维素钠或聚乙烯吡咯烷酮中的一种;The filler is selected from one of starch, pregelatinized starch, microcrystalline cellulose, sodium carboxymethylcellulose or polyvinylpyrrolidone;
崩解剂选自羧甲基淀粉钠、羧甲基纤维素钠或其混合物,润滑剂选自硬脂酸镁或滑石粉,湿润剂选自水、乙醇溶液或聚乙烯吡咯烷酮的乙醇溶液中的一种。The disintegrating agent is selected from sodium carboxymethyl starch, sodium carboxymethylcellulose or their mixtures, the lubricant is selected from magnesium stearate or talcum powder, and the wetting agent is selected from water, ethanol solution or polyvinylpyrrolidone in ethanol solution A sort of.
上述的半夏泻心汤制剂包括片剂和胶囊剂。The above-mentioned Banxia Xiexin Decoction preparation includes tablets and capsules.
上述的半夏泻心汤制剂的制备方法包括如下步骤:The preparation method of above-mentioned Banxia Xiexin Decoction preparation comprises the steps:
以上原料用15~25倍量的水或15~22倍量的50%~80%的乙醇溶液回流提取,提取时间为1~2小时,最好分2~3次回流提取,每次1~2小时,合并提取液,过滤,滤液浓缩至60℃时的相对密度为1.05~1.15,喷雾干燥或减压干燥得到提取物粉末。The above raw materials are reflux extracted with 15 to 25 times the amount of water or 15 to 22 times the amount of 50% to 80% ethanol solution. The extraction time is 1 to 2 hours. After 2 hours, the extracts were combined, filtered, the filtrate was concentrated to a relative density of 1.05-1.15 at 60° C., and spray-dried or dried under reduced pressure to obtain extract powder.
喷雾干燥时进风口温度为120~160℃;减压干燥的真空度为-0.06~-0.1MPa。The air inlet temperature during spray drying is 120-160°C; the vacuum degree of decompression drying is -0.06--0.1MPa.
提取物粉末过筛,加入填充剂、崩解剂及湿润剂以本领域公知的方法湿法制颗粒,或加入填充剂、崩解剂以本领域公知的方法干压法制粒,即获得本发明的半夏泻心汤制剂;The extract powder is sieved, adding fillers, disintegrants and wetting agents to wet granules by methods known in the art, or adding fillers and disintegrants to dry granules by methods known in the art to obtain the granules of the present invention. Banxia Xiexin Decoction preparation;
将所获得的制剂装填于胶囊中,即获得半夏泻心汤胶囊剂;Fill the obtained preparation in capsules to obtain Banxia Xiexin Decoction capsules;
或进一步在半夏泻心汤制剂中加入润滑剂以本领域公知的方法压片,用薄膜包衣,即获得半夏泻心汤片剂。Or further add a lubricant to the Banxia Xiexin Decoction preparation, compress into tablets by a method known in the art, and coat with a film to obtain Banxia Xiexin Decoction tablets.
本发明的半夏泻心汤制剂,包括胶囊剂和片剂,可用于治疗慢性胃炎、胃溃疡等疾病,常用的剂量为1.0~2.0克/50公斤体重,具体可根据患者的年龄、性别和病情决定。The Banxia Xiexin Decoction preparation of the present invention, including capsules and tablets, can be used to treat diseases such as chronic gastritis and gastric ulcer. The disease decides.
本发明是以服用方便的现代剂型取代传统剂型,本发明的特点是,原料配比合理,精提有效成分,减少服用量,所制胶囊剂和片剂的崩解迅速,使药物受胃排空影响较小,在治疗部位疗充分发挥治疗作用。The invention replaces the traditional dosage form with a modern dosage form that is convenient to take. The characteristics of the invention are that the ratio of raw materials is reasonable, the active ingredients are refined and the dosage is reduced, and the prepared capsules and tablets disintegrate quickly, so that the medicine can be excreted by the stomach. The effect of air is small, and the therapeutic effect can be fully exerted at the treatment site.
用本方法制备的半夏泻心片或胶囊有效成分含量高,对浅表性胃炎尤其是幽门螺杆菌引起的胃炎、胃溃疡具有良好的疗效,服用方便,服用量少。The Banxia Xiexin tablet or capsule prepared by the method has high content of active ingredients, has good curative effect on superficial gastritis, especially gastritis and gastric ulcer caused by Helicobacter pylori, is convenient to take, and has a small dosage.
具体实施方式Detailed ways
实施例1Example 1
按半夏泻心汤处方称取2kg药材,其中:Weigh 2kg of medicinal materials according to the prescription of Banxia Xiexin Decoction, of which:
药材半夏 0.46kg,黄芩 0.33kg,人参 0.33kg,干姜 0.32,Medicinal Pinellia 0.46kg, Scutellaria baicalensis 0.33kg, Ginseng 0.33kg, Dried Ginger 0.32,
大枣 0.32kg,炙甘草 0.19kg,黄连 0.05kgJujube 0.32kg, Zhigancao 0.19kg, Coptis 0.05kg
用36kg的70%乙醇溶液,水浴加热回流提取两次,第一次加20kg,提取2h,第二次加16kg,提取1h;过滤,滤液浓缩至25℃时的相对密度为1.1,喷雾干燥得到提取物粉末。提取物粉末过筛,加入微晶纤维素148g,聚乙烯吡咯烷酮26g和羧甲基纤维素钠26g,以干压法制粒,整粒后填充胶囊制成半夏泻心胶囊。Use 36kg of 70% ethanol solution, heat and reflux in a water bath to extract twice, add 20kg for the first time, extract for 2h, add 16kg for the second time, extract for 1h; filter, and the relative density of the filtrate when concentrated to 25°C is 1.1, spray-dried to obtain Extract powder. The extract powder was sieved, added 148g of microcrystalline cellulose, 26g of polyvinylpyrrolidone and 26g of sodium carboxymethylcellulose, granulated by dry pressing, and filled with capsules to make Banxia Xiexin Capsules.
实施例2Example 2
按半夏泻心汤处方称取2kg药材,其中:Weigh 2kg of medicinal materials according to the prescription of Banxia Xiexin Decoction, of which:
药材半夏 0.40,黄芩 0.31, 党参 0.32,干姜 0.32,Medicinal Pinellia 0.40, Scutellaria baicalensis 0.31, Codonopsis 0.32, dried ginger 0.32,
大枣 0.31,炙甘草 0.21, 黄连 0.13。Jujube 0.31, Zhigancao 0.21, Coptis 0.13.
用44kg的60%乙醇溶液,水浴加热回流提取两次,第一次加24kg,提取2h,第二次加20kg,提取1h;过滤,滤液浓缩至25℃时的相对密度为1.1,喷雾干燥得到提取物粉末。提取物粉末过筛,加入微晶纤维素148g,聚乙烯吡咯烷酮26g和羧甲基纤维素钠26g,以干压法制粒,整粒后填充胶囊制成半夏泻心胶囊。Use 44kg of 60% ethanol solution, heat and reflux in a water bath to extract twice, add 24kg for the first time, extract for 2h, add 20kg for the second time, extract for 1h; filter, the relative density of the filtrate when concentrated to 25°C is 1.1, and spray dry to obtain Extract powder. The extract powder was sieved, added 148g of microcrystalline cellulose, 26g of polyvinylpyrrolidone and 26g of sodium carboxymethylcellulose, granulated by dry pressing, and filled with capsules to make Banxia Xiexin Capsules.
实施例3Example 3
采用实施例2的方法,并以本领域公知的方法干压法制粒,整粒后加硬脂酸镁4g压片,制得半夏泻心片,片剂用丙烯酸树脂采用公知的方法包薄膜衣。Adopt the method of Example 2, and granulate by dry pressing method known in the art, add magnesium stearate 4g tabletting after granulation, make Pinellia Xiexin Tablet, acrylic resin adopts known method film-coating for tablet Clothes.
实施例4Example 4
根据与实施例1相同的方法,将干燥方法改为减压干燥,干燥物经粉碎后得提取物粉末。According to the same method as in Example 1, the drying method was changed to drying under reduced pressure, and the dried product was pulverized to obtain extract powder.
实施例4Example 4
根据与实施例2相同的方法,将“70%乙醇溶液,水浴加热回流提取两次”改为“水煎煮2次”。According to the same method as in Example 2, change "70% ethanol solution, extract twice under reflux in a water bath" to "decoct in water twice".
实施例5Example 5
半夏泻心汤片剂与胶囊剂对幽门螺杆菌感染胃炎模型的药效学研究Pharmacodynamic study of Banxia Xiexin Decoction tablets and capsules on Helicobacter pylori-infected gastritis model
1、实验材料1. Experimental materials
药品和试剂 半夏泻心汤片剂与胶囊剂(自制),丽珠得乐(珠海丽珠制药厂生产),尿激酶、氧化酶、过氧化氢酶(购自Sigerma公司),0.9%氯化钠注射液、5%Na2HCO3溶液、PBS溶液(自配)。Drugs and reagents Banxia Xiexin Decoction tablets and capsules (self-made), Livzon Dele (produced by Zhuhai Livzon Pharmaceutical Factory), urokinase, oxidase, catalase (purchased from Sigerma), 0.9% chlorine Sodium chloride injection, 5% Na 2 HCO 3 solution, PBS solution (prepared by yourself).
动物Wister大鼠,4月龄,体重112~158g,由本院动物中心提供。Animals Wister rats, 4 months old, weighing 112-158 g, were provided by the Animal Center of our hospital.
2、方法2. Method
2.1供试验用药物样品的配制按表1中剂量,用0.9%氯化钠注射液配制成适宜的浓度供试验用。2.1 Preparation of drug samples for testing According to the dosage in Table 1, use 0.9% sodium chloride injection to prepare a suitable concentration for testing.
2.2幽门螺杆菌(HP)感染模型的制备2.2 Preparation of Helicobacter pylori (HP) infection model
2.2.1 HP菌株培养 取胃镜室检查的慢性活动性胃炎患者胃粘膜组织钳取物,接种于空肠弯曲菌选择性培养基上,置微氧环境,37℃培养72小时,检查菌落,革兰氏染色为阴性杆菌,尿激酶、氧化酶、过氧化氢酶试验阳性,确定为HP菌后,传代培养做为试验菌株。2.2.1 HP strain culture Take the gastric mucosal tissue forceps of patients with chronic active gastritis examined in the gastroscope room, inoculate it on Campylobacter jejuni selective medium, place it in a micro-aerobic environment, and culture it at 37°C for 72 hours, check the colonies, Gram Negative bacillus stained with urokinase, oxidase, and catalase were positive. After confirming that it was HP bacteria, it was subcultured as the test strain.
2.2.2 感染方法 取Wister大鼠176只,雌雄各半,随机分成12组(其中2组为8只,1组为空白组,不进行HP感染),每组16只,分笼饲养。禁食12小时后用5% Na2HCO3溶液2ml/只ig,15min后给混合Hp菌株(1012cfu/L菌液)2ml/只ig,30min后进食。每周感染1次,共4次。2.2.2 Infection method 176 Wister rats, half male and half male, were randomly divided into 12 groups (two groups consisted of 8 rats, and one group was a blank group without HP infection), 16 rats in each group, and raised in separate cages. After fasting for 12 hours, use 5% Na 2 HCO 3 solution 2ml/ig for ig, give mixed Hp strains (10 12 cfu/L bacterial solution) 2ml/ig for 15min, and eat after 30min. 1 infection per week, 4 times in total.
2.3抗Hp感染胃炎试验2.3 Anti-Hp infection gastritis test
2.3.1实验分组与给药方法 Hp末次感染一周后,分别按下列分组给药:样品低剂量组(1号、2号、3号、4号各一组)、样品高剂量组(1号、2号、3号、4号各一组)、NS对照组、阳性药(丽珠得乐)对照组,每天ig给药1次,疗程10天。给药剂量见表1。给药结束后将上述10组每组随机分成2组,各8只,分别于治疗结束后次日和结束后1个月急性处死动物,无菌操作取胃,沿胃大弯剪开,PBS液洗去胃内容物,在幽门端相对固定部位取5块组织,供直接涂片、尿素酶试验、Hp培养,其余放入由PBS液配制的10%甲醛液中固定,供病理学检查。病理学检查方法:将胃组织切片用HE染色,用显微镜观察各受试动物胃粘膜的病变情况。2.3.1 Experimental grouping and administration method One week after the last Hp infection, the administration was divided into the following groups: low-dose sample group (one group for No. 1, No. 2, No. 3, and No. 4), high-dose sample group (No. , No. 2, No. 3, and No. 4 each group), NS control group, positive drug (Livzon Dele) control group, ig administration once a day, and the course of treatment was 10 days. The dosage is shown in Table 1. After the administration, the above 10 groups were randomly divided into 2 groups, 8 animals in each group, and the animals were sacrificed acutely on the day after the end of treatment and 1 month after the end of treatment, and the stomach was taken out by aseptic operation, cut open along the greater curvature of the stomach, and PBS The contents of the stomach were washed away with liquid, and 5 pieces of tissue were taken from relatively fixed parts of the pyloric end for direct smear, urease test, and Hp culture, and the rest were fixed in 10% formaldehyde solution prepared by PBS solution for pathological examination. Pathological examination method: The gastric tissue sections were stained with HE, and the pathological changes of the gastric mucosa of each tested animal were observed with a microscope.
2.3.2 结果判断 Hp三项检查:涂片镜检未检查到Hp、尿素酶试验反应阴性、Hp培养未见HP者为转阴,以转阴动物数计算每组转阴率,治疗后的转阴率为HP清除率,治疗结束一个月后的HP转阴率为根除率。2.3.2 Judgment of results The three tests of Hp: no Hp detected by smear microscopy, negative urease test reaction, and no HP found in Hp culture were negative conversion, and the negative conversion rate of each group was calculated based on the number of negative animals. The negative conversion rate was the HP clearance rate, and the HP negative conversion rate was the eradication rate one month after the end of treatment.
3、结果3. Results
3.1 HP感染胃炎模型制备 任意抽取一组HP感染组,取胃粘膜组织进行涂片镜检、尿激酶试验,感染组中8只鼠均能检测到HP,空白对照组8只大鼠胃粘膜组织均未检测到HP。3.1 Preparation of HP-infected gastritis model A group of HP-infected groups were randomly selected, and gastric mucosal tissues were taken for smear microscopy and urokinase test. HP could be detected in 8 rats in the infection group, and gastric mucosal tissues of 8 rats in the blank control group Neither HP was detected.
3.2受试样品抗HP作用3.2 Anti-HP effect of tested samples
3.2.1 对HP的清除率和根除率各试药组和阳性对照药组均对HP有一定的清除率和根除率,半夏泻心汤片剂与胶囊剂高剂量组与阳性对照药组效果较好,与对照组比较差异非常显著(P<0.01),其它各组也具有一定的抗HP作用,与对照组比较差异均具有显著性(P<0.05)。其中,半夏泻心汤片剂与胶囊剂高剂量组与阳性对照药组效果相当,相互间差异无显著性(P>0.05)。结果见表1。3.2.1 The clearance rate and eradication rate of HP Each test group and the positive control drug group have a certain clearance rate and eradication rate of HP, Banxia Xiexin Decoction tablet and capsule high dose group and the positive control drug group The effect is better, and the difference is very significant compared with the control group (P<0.01). Other groups also have certain anti-HP effects, and the difference is significant compared with the control group (P<0.05). Among them, the high-dose group of Banxia Xiexin Decoction tablets and capsules had the same effect as the positive control group, and there was no significant difference between them (P>0.05). The results are shown in Table 1.
表1 各组对HP的清除率和根除率
组别 给药剂量 对HP清除率 对HP根除率Groups Dosage on HP clearance rate on HP eradication rate
(mg/kg) N HP转阴数 清除率(%) HP转阴数 根除率(%) (mg/kg) N Clearance rate (%) Negative number of HP eradication rate (%)
生理盐水对照组 20ml/kg 8 1 12.5 0 0Normal saline control group 20ml/kg 8 1 12.5 0 0
半夏泻心汤片剂低剂 150 8 3 37.5 1 12.5Banxia Xiexin Decoction Tablet Low Dose 150 8 3 37.5 1 12.5
量组Quantity group
半夏泻心汤片剂高剂 200 8 6 75.0 5 62.5Banxia Xiexin Decoction Tablet High Dosage 200 8 6 75.0 5 62.5
量组Quantity group
半夏泻心汤胶囊剂低 100 8 5 62.5 4 50.0Banxia Xiexin Decoction Capsules Low 100 8 5 62.5 4 50.0
剂量组Dose group
半夏泻心汤胶囊剂高 200 8 7 87.5 6 75.0Banxia Xiexin Decoction Capsule High 200 8 7 87.5 6 75.0
剂量组Dose group
丽珠得乐组 40 8 7 87.5 6 75.0Livzon Dele Group 40 8 7 87.5 6 75.0
3.2.2病理变化 生理盐水对照组:胃粘膜腺体破坏,间质水肿伴炎性细胞浸润。半夏泻心汤片剂低剂量组:胃粘膜灶性炎症细胞反应。半夏泻心汤片剂高剂量组、半夏泻心汤胶囊剂低剂量组:胃粘膜腺体正常,浅层有少量炎症细胞。高剂量半夏泻心汤胶囊剂高剂量组与丽珠得乐组:胃腺正常,未见炎症细胞。3.2.2 Pathological changes Normal saline control group: destruction of gastric mucosal glands, interstitial edema with inflammatory cell infiltration. Banxia Xiexin Decoction Tablet Low-dose Group: Focal inflammatory cell response in gastric mucosa. In the high-dose group of Banxia Xiexin Decoction tablets and the low-dose group of Banxia Xiexin Decoction capsules: gastric mucosal glands were normal, with a small amount of inflammatory cells in the superficial layer. High-dose Banxia Xiexin Tang capsule high-dose group and Livzon Dele group: the gastric glands were normal and no inflammatory cells were seen.
4、小结4. Summary
研究结果表明,半夏泻心汤片剂与胶囊剂均具有较好的抗HP作用,其中半夏泻心汤胶囊剂高剂量组效果最佳,与阳性对照药抗HP作用相当。The research results showed that both Banxia Xiexin Decoction tablets and capsules had good anti-HP effects, and the high-dose Banxia Xiexin Decoction capsule group had the best effect, which was equivalent to the anti-HP effect of the positive control drug.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100184321A CN100376287C (en) | 2004-05-18 | 2004-05-18 | Banxia Xiexin Decoction preparation and its preparation method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100184321A CN100376287C (en) | 2004-05-18 | 2004-05-18 | Banxia Xiexin Decoction preparation and its preparation method and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1698669A true CN1698669A (en) | 2005-11-23 |
| CN100376287C CN100376287C (en) | 2008-03-26 |
Family
ID=35475020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100184321A Expired - Fee Related CN100376287C (en) | 2004-05-18 | 2004-05-18 | Banxia Xiexin Decoction preparation and its preparation method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100376287C (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101780263A (en) * | 2010-03-25 | 2010-07-21 | 江苏济川制药有限公司 | Traditional Chinese medicine composition for treating chronic gastritis and preparation method thereof |
| CN101797370A (en) * | 2010-04-02 | 2010-08-11 | 吕红权 | Traditional Chinese medicinal composition for treating gastroptosis |
| CN102614481A (en) * | 2011-10-18 | 2012-08-01 | 宋协勘 | Chinese medicine for treating chronic gastritis |
| CN102743735A (en) * | 2012-07-25 | 2012-10-24 | 黑龙江中医药大学 | Preparation method of pinellia tuber heart-fire purging decoction gastric stagnation tablet |
| CN102764422A (en) * | 2012-08-17 | 2012-11-07 | 河南中医学院 | Xialian Yiyou capsule for curing chronic gastritis |
| CN102772759A (en) * | 2012-07-05 | 2012-11-14 | 李承平 | Group of tablets for clearing heat, eliminating mass and removing stasis |
| CN103479992A (en) * | 2013-10-14 | 2014-01-01 | 张桂赫 | Traditional Chinese medicine pill for treating anxiety neurosis accompanied with digestive tract symptom and preparation method thereof |
| CN106421684A (en) * | 2016-08-26 | 2017-02-22 | 广西慧投互联网金融服务有限公司 | Composition capable of diminishing inflammation and strengthening stomach |
| CN110269925A (en) * | 2018-09-25 | 2019-09-24 | 李世昌 | A kind of stomach medicine and preparation method for treating atrophic gastritis |
| CN117281880A (en) * | 2023-04-24 | 2023-12-26 | 天津津骁信息咨询有限公司 | A traditional Chinese medicine composition for treating gastric precancerous lesions and its preparation method and application |
-
2004
- 2004-05-18 CN CNB2004100184321A patent/CN100376287C/en not_active Expired - Fee Related
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101780263A (en) * | 2010-03-25 | 2010-07-21 | 江苏济川制药有限公司 | Traditional Chinese medicine composition for treating chronic gastritis and preparation method thereof |
| CN101797370A (en) * | 2010-04-02 | 2010-08-11 | 吕红权 | Traditional Chinese medicinal composition for treating gastroptosis |
| CN101797370B (en) * | 2010-04-02 | 2011-10-26 | 吕红权 | Traditional Chinese medicinal composition for treating gastroptosis |
| CN102614481A (en) * | 2011-10-18 | 2012-08-01 | 宋协勘 | Chinese medicine for treating chronic gastritis |
| CN102772759A (en) * | 2012-07-05 | 2012-11-14 | 李承平 | Group of tablets for clearing heat, eliminating mass and removing stasis |
| CN102743735A (en) * | 2012-07-25 | 2012-10-24 | 黑龙江中医药大学 | Preparation method of pinellia tuber heart-fire purging decoction gastric stagnation tablet |
| CN102743735B (en) * | 2012-07-25 | 2014-07-23 | 黑龙江中医药大学 | Preparation method of pinellia tuber heart-fire purging decoction gastric stagnation tablet |
| CN102764422A (en) * | 2012-08-17 | 2012-11-07 | 河南中医学院 | Xialian Yiyou capsule for curing chronic gastritis |
| CN103479992A (en) * | 2013-10-14 | 2014-01-01 | 张桂赫 | Traditional Chinese medicine pill for treating anxiety neurosis accompanied with digestive tract symptom and preparation method thereof |
| CN106421684A (en) * | 2016-08-26 | 2017-02-22 | 广西慧投互联网金融服务有限公司 | Composition capable of diminishing inflammation and strengthening stomach |
| CN110269925A (en) * | 2018-09-25 | 2019-09-24 | 李世昌 | A kind of stomach medicine and preparation method for treating atrophic gastritis |
| CN117281880A (en) * | 2023-04-24 | 2023-12-26 | 天津津骁信息咨询有限公司 | A traditional Chinese medicine composition for treating gastric precancerous lesions and its preparation method and application |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100376287C (en) | 2008-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1274298C (en) | Disintegrants for deodoring effectively and their preparation | |
| CN1857681A (en) | Gastropathy treating preparation and its preparing process | |
| CN111479559A (en) | Tablet-coated composite preparation containing mosapride and rabeprazole | |
| CN1698669A (en) | Banxia Xiexin Decoction preparation and its preparation method and application | |
| CN1836720A (en) | A kind of traditional Chinese medicine composition for treating arthritis or gout and preparation method thereof | |
| CN1813686A (en) | Montelukast oral disintegrating tablet formulation and its preparing method | |
| CN1611215A (en) | Application of dihydromyricetin in preparation of medicine | |
| CN1608662A (en) | Medicine with antiphlogistic, analgetic, microbiostatic and diuretic effects | |
| CN1772081A (en) | Diarrhea treating chinese medicine composition | |
| CN114177142B (en) | Praxifloxacin enteric solid dispersion and preparation containing same | |
| CN113425697B (en) | Preparation and preliminary pharmaceutical evaluation method of compound qi-tonifying intestine-moistening capsule | |
| CN104510854B (en) | A kind of Chinese medicine composition for the treatment of dysmenorrhes and uses thereof | |
| CN1290528C (en) | Medicine for treating toothache | |
| WO2013177833A1 (en) | Dysmenorrhea-treating medicament and preparation method therefor | |
| TW202126320A (en) | Anisomeles indica bioactive fractions TSYI-813 for treatment or improvement efficacies of stomach ulcer, and compound, preparation method and purpose thereof do not only reduce areas of stomach ulcer but also decrease occurrence of stomach inflammation | |
| CN1537620A (en) | Traditional Chinese medicine slow-release oral adhesive tablet for treating oral mucosal diseases and preparation method thereof | |
| CN1772234A (en) | Chinese medicine prepn for treating women's disease and its prepn | |
| CN1823961B (en) | Compound Chinese medicine for treating cough and panting, acute bronchitis caused by common cold and its preparation method | |
| CN110152003B (en) | A kind of compound medicine for treating COPD and preparation method thereof | |
| CN100500178C (en) | A traditional Chinese medicine preparation for treating gynecological diseases and its preparation method | |
| CN1806833A (en) | Compound vitex negundo capsule, preparation method and uses thereof | |
| CN1733084A (en) | Chinese medicinal preparation for clearing pathological heat and toxin and preparation process thereof | |
| CN1943617A (en) | Qiwei blood disease tablet, capsule and its preparing method | |
| CN118059160A (en) | Medicine for treating ulcerative colitis and preparation method and application thereof | |
| CN1660357A (en) | Capsule of tin liked powder released at localization of colon and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| DD01 | Delivery of document by public notice |
Addressee: Shanghai Institute of pharmaceutical industry Document name: Notification of Termination of Patent Right |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080326 Termination date: 20150518 |
|
| EXPY | Termination of patent right or utility model |